These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8206214)

  • 21. Dopamine and Huntington's disease.
    Schwab LC; Garas SN; Drouin-Ouellet J; Mason SL; Stott SR; Barker RA
    Expert Rev Neurother; 2015 Apr; 15(4):445-58. PubMed ID: 25773746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Understanding of PDE10A in the Modulation of Basal Ganglia Circuitry.
    Schülke JP; Brandon NJ
    Adv Neurobiol; 2017; 17():15-43. PubMed ID: 28956328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonergic-dopaminergic interactions and extrapyramidal function.
    Chase TN
    Adv Biochem Psychopharmacol; 1974; 11(0):377-85. PubMed ID: 4367649
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system.
    Smits SM; Mathon DS; Burbach JP; Ramakers GM; Smidt MP
    Mol Cell Neurosci; 2005 Nov; 30(3):352-63. PubMed ID: 16140547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The aging striatal dopamine function.
    Darbin O
    Parkinsonism Relat Disord; 2012 Jun; 18(5):426-32. PubMed ID: 22176812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: G.A.B.A. and Huntington's chorea.
    Barbeau A
    Lancet; 1973 Dec; 2(7844):1499-500. PubMed ID: 4129342
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease.
    Strange PG
    Mov Disord; 1993 Jul; 8(3):263-70. PubMed ID: 8101967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Images in neuroscience. Neuroimaging, XII. SPECT imaging of dopamine nerve terminals.
    Seibyl JP; Marek K; Innis RB
    Am J Psychiatry; 1996 Sep; 153(9):1131. PubMed ID: 8780413
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacology of tardive dyskinesias.
    Klawans HL
    Am J Psychiatry; 1973 Jan; 130(1):82-6. PubMed ID: 4264755
    [No Abstract]   [Full Text] [Related]  

  • 30. Dopamine receptors, motor responses, and dopaminergic agonists.
    Luquin-Piudo MR; Sanz P
    Neurologist; 2011 Nov; 17(6 Suppl 1):S2-8. PubMed ID: 22045321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
    Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
    Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hard target: understanding dopaminergic neurotransmission.
    Nestler EJ
    Cell; 1994 Dec; 79(6):923-6. PubMed ID: 8001139
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.
    Hara M; Fukui R; Hieda E; Kuroiwa M; Bateup HS; Kano T; Greengard P; Nishi A
    J Neurochem; 2010 May; 113(4):1046-59. PubMed ID: 20236221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
    Hornykiewicz O
    Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131
    [No Abstract]   [Full Text] [Related]  

  • 35. Parkinsonism: candidate disorder for implanted pumps?
    Nutt JG
    Ann N Y Acad Sci; 1988; 531():194-9. PubMed ID: 2898229
    [No Abstract]   [Full Text] [Related]  

  • 36. Parkinson's disease: presenting a gray box model.
    Gharibzadeh S; Sarbaz Y; Towhidkhah F
    J Neuropsychiatry Clin Neurosci; 2009; 21(4):470-1. PubMed ID: 19996260
    [No Abstract]   [Full Text] [Related]  

  • 37. Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: studies in postmortem tissues and in rats with kainic acid lesions.
    Melamed E; Hefti F; Bird ED
    Neurology; 1982 Jun; 32(6):640-4. PubMed ID: 6211637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease.
    Elsworth JD; Roth RH
    Exp Neurol; 1997 Mar; 144(1):4-9. PubMed ID: 9126143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neostriatal dopamine receptors.
    Bloch B; Le Moine C
    Trends Neurosci; 1994 Jan; 17(1):3-4; author reply 4-5. PubMed ID: 7511847
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterogeneous dopamine receptor changes in early and late Huntington's disease.
    Richfield EK; O'Brien CF; Eskin T; Shoulson I
    Neurosci Lett; 1991 Oct; 132(1):121-6. PubMed ID: 1838580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.